Years of life lost due to unintentional drug overdose among perinatal individuals in the United States

Bhadra-Heintz, Nia M.; Garcia, Stephanie; Entrup, Parker; Trimble, Candice; Teater, Julie; Rood, Kara M.; Hall, O.

doi:10.1016/j.srhc.2023.100842

Cited by 1 publication

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Untreated substance use disorder (SUD) during pregnancy and postpartum is associated with an increased risk of overdose death and severe maternal morbidity in the United States (US) [1][2][3]. From 2018 to 2021, there was a significant increase in overdose deaths during pregnancy and postpartum, matching a trend of increasing overdose deaths across the US [1].…”

Section: Rationalementioning

confidence: 99%

“…Persistent structural and institutional inequities, particularly at the intersections of racism, genderism, sexism, and classism, also contribute to gaps in the adoption and delivery of equitable and evidence-informed practices [ 21 , 22 ]. Increases in unintentional drug overdoses are particularly concerning among American Indian/Native American and Black birthing people [ 3 ]. Yet, Black and Hispanic persons are less likely than White persons to receive MOUD during pregnancy [ 23 , 24 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Strategies to improve delivery of equitable and evidence-informed care for pregnant and birthing people with a substance use disorder in acute care settings: A scoping review protocol

King,

Laynor,

McNeely

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

This protocol outlines a proposed scoping review to characterize evidence on implementation and quality improvement (QI) strategies that aim to improve equitable, evidence-informed care delivery for pregnant and birthing people with substance use disorder (SUD) in acute care. Untreated SUD during pregnancy is associated with an increased risk of overdose and severe maternal morbidity. Acute care settings are one important place to deliver equitable, evidence-informed clinical care. While clinical practice guidelines for substance use treatment and care of pregnant and birthing people with SUD exist, there are gaps in implementation. Our population of interest is pregnant and birthing people with SUD in an acute care setting. We will include US-based studies that describe or evaluate implementation or QI strategies, including experimental, observational, and descriptive studies published from 2016 to 2023. The proposed scoping review will be conducted in accordance with JBI methodology for scoping reviews and registered at OSF (registration number: BC4VZ). We will search MEDLINE (PubMed), CINAHL Complete (EBSCO), Scopus (Elsevier), and APA PsychInfo (Ovid) for published studies. Conference proceedings and Perinatal Quality Collaborative websites will be searched for grey literature. Two reviewers will independently screen then extract studies that meet inclusion criteria using a data extraction tool. The completion of this scoping review will help illuminate strengths and gaps in research and practice that aim to inform substance use treatment and care in acute care settings for pregnant and birthing people with SUD.

show abstract